Latest Insider Transactions at Integra Lifesciences Holdings Corp (IART)
This section provides a real-time view of insider transactions for Integra Lifesciences Holdings Corp (IART). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of INTEGRA LIFESCIENCES HOLDINGS CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of INTEGRA LIFESCIENCES HOLDINGS CORP's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 01
2024
|
Jan De Witte President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,262
-15.13%
|
$80,978
$19.28 P/Share
|
|
Nov 01
2024
|
Jan De Witte President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,814
+25.84%
|
-
|
|
Sep 01
2024
|
Chantal Veillon Berteloot EVP & CHRO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,412
-5.47%
|
$28,240
$20.34 P/Share
|
|
Aug 19
2024
|
Jeffrey Mosebrook SVP, Fin & Princ Acct Officer |
SELL
Open market or private sale
|
Direct |
1,191
-3.19%
|
$25,011
$21.58 P/Share
|
|
Jul 03
2024
|
Lea Daniels Knight EVP & CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,561
-5.76%
|
$71,708
$28.73 P/Share
|
|
Jul 01
2024
|
Jeffrey Mosebrook SVP, Fin & Princ Acct Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,356
+21.74%
|
-
|
|
May 23
2024
|
Stuart Essig Exec. Chairman of the Board |
BUY
Open market or private purchase
|
Direct |
52,641
+9.74%
|
$1,473,948
$28.49 P/Share
|
|
May 21
2024
|
Barbara B Hill Director |
BUY
Open market or private purchase
|
Indirect |
36,350
+50.0%
|
$981,450
$27.4 P/Share
|
|
May 12
2024
|
Keith Bradley Director |
SELL
Payment of exercise price or tax liability
|
Direct |
239
-0.17%
|
$5,975
$25.99 P/Share
|
|
May 09
2024
|
Stuart Essig Exec. Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
13,835
+0.73%
|
-
|
|
May 09
2024
|
Barbara B Hill Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,859
+5.66%
|
-
|
|
May 09
2024
|
Jeffrey A Graves Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,278
+35.22%
|
-
|
|
May 09
2024
|
Shaundra Clay Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,696
+28.4%
|
-
|
|
May 09
2024
|
Renee Wonlai Lo Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,696
+35.0%
|
-
|
|
May 09
2024
|
Raymond G. Murphy Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,696
+13.87%
|
-
|
|
May 09
2024
|
Christian S Schade Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,696
+12.04%
|
-
|
|
May 09
2024
|
Keith Bradley Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,696
+11.03%
|
-
|
|
Mar 12
2024
|
Robert T. Davis Jr. EVP & President, TT |
SELL
Payment of exercise price or tax liability
|
Direct |
2,024
-1.52%
|
$70,840
$35.88 P/Share
|
|
Mar 12
2024
|
Jeffrey Mosebrook SVP, Fin & Princ Acct Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
347
-0.64%
|
$12,145
$35.88 P/Share
|
|
Mar 12
2024
|
Eric Schwartz EVP, Chief Legal Officer & Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
1,438
-1.11%
|
$50,330
$35.88 P/Share
|
|
Mar 12
2024
|
Michael J. Mc Breen EVP & President, CSS |
SELL
Payment of exercise price or tax liability
|
Direct |
2,012
-1.69%
|
$70,420
$35.88 P/Share
|
|
Mar 11
2024
|
Robert T. Davis Jr. EVP & President, TT |
BUY
Grant, award, or other acquisition
|
Direct |
20,283
+13.94%
|
-
|
|
Mar 11
2024
|
Robert T. Davis Jr. EVP & President, TT |
SELL
Payment of exercise price or tax liability
|
Direct |
2,410
-2.46%
|
$86,760
$36.22 P/Share
|
|
Mar 11
2024
|
Jan De Witte President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
205
-1.1%
|
$7,380
$36.22 P/Share
|
|
Mar 11
2024
|
Jan De Witte President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
205
+1.09%
|
-
|
|
Mar 11
2024
|
Jeffrey Mosebrook SVP, Fin & Princ Acct Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,410
+11.11%
|
-
|
|
Mar 11
2024
|
Jeffrey Mosebrook SVP, Fin & Princ Acct Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
130
-0.54%
|
$4,680
$36.22 P/Share
|
|
Mar 11
2024
|
Lea Daniels Knight EVP & CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
20,105
+20.15%
|
-
|
|
Mar 11
2024
|
Chantal Veillon Berteloot EVP & CHRO |
BUY
Grant, award, or other acquisition
|
Direct |
11,758
+20.43%
|
-
|
|
Mar 11
2024
|
Eric Schwartz EVP, Chief Legal Officer & Sec |
BUY
Grant, award, or other acquisition
|
Direct |
16,028
+11.66%
|
-
|
|
Mar 11
2024
|
Eric Schwartz EVP, Chief Legal Officer & Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
1,371
-2.72%
|
$49,356
$36.22 P/Share
|
|
Mar 11
2024
|
Michael J. Mc Breen EVP & President, CSS |
BUY
Grant, award, or other acquisition
|
Direct |
20,503
+15.65%
|
-
|
|
Mar 11
2024
|
Michael J. Mc Breen EVP & President, CSS |
SELL
Payment of exercise price or tax liability
|
Direct |
3,922
-4.57%
|
$141,192
$36.22 P/Share
|
|
Mar 10
2024
|
Eric Schwartz EVP, Chief Legal Officer & Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
799
-1.56%
|
$28,764
$36.73 P/Share
|
|
Mar 10
2024
|
Michael J. Mc Breen EVP & President, CSS |
SELL
Payment of exercise price or tax liability
|
Direct |
2,655
-2.93%
|
$95,580
$36.73 P/Share
|
|
Mar 10
2024
|
Robert T. Davis Jr. EVP & President, TT |
SELL
Payment of exercise price or tax liability
|
Direct |
635
-1.27%
|
$22,860
$36.73 P/Share
|
|
Mar 10
2024
|
Harvinder Singh EVP & PRESIDENT, INTERNATIONAL |
BUY
Exercise of conversion of derivative security
|
Direct |
1,179
+50.0%
|
-
|
|
Mar 10
2024
|
Jan De Witte President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
346
-1.85%
|
$12,456
$36.73 P/Share
|
|
Mar 10
2024
|
Jan De Witte President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
346
+1.82%
|
-
|
|
Mar 10
2024
|
Jeffrey Mosebrook SVP, Fin & Princ Acct Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
276
-0.57%
|
$9,936
$36.73 P/Share
|
|
Mar 06
2024
|
Robert T. Davis Jr. EVP & President, TT |
SELL
Open market or private sale
|
Direct |
8,348
-14.33%
|
$300,528
$36.59 P/Share
|
|
Mar 06
2024
|
Robert T. Davis Jr. EVP & President, TT |
BUY
Exercise of conversion of derivative security
|
Direct |
8,736
+13.04%
|
$279,552
$32.59 P/Share
|
|
Feb 20
2024
|
Michael J. Mc Breen EVP & President, CSS |
BUY
Grant, award, or other acquisition
|
Direct |
3,516
+7.11%
|
-
|
|
Feb 20
2024
|
Eric Schwartz EVP, Chief Legal Officer & Sec |
BUY
Grant, award, or other acquisition
|
Direct |
2,564
+4.77%
|
-
|
|
Feb 20
2024
|
Jeffrey Mosebrook SVP, Fin & Princ Acct Officer |
BUY
Grant, award, or other acquisition
|
Direct |
808
+3.22%
|
-
|
|
Feb 20
2024
|
Robert T. Davis Jr. EVP & President, TT |
BUY
Grant, award, or other acquisition
|
Direct |
3,721
+6.99%
|
-
|
|
Jan 18
2024
|
Jan De Witte President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
597
-3.15%
|
$25,074
$42.39 P/Share
|
|
Jan 18
2024
|
Jan De Witte President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
597
+3.05%
|
-
|
|
Dec 12
2023
|
Jeffrey A Graves Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,216
+50.0%
|
-
|
|
Nov 01
2023
|
Jan De Witte President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,262
-18.85%
|
$153,432
$36.85 P/Share
|